misonneh's prediction [33 articles] Export

Recent papers added to misonneh's library classified by the tag prediction. You can also see everyone's prediction.

	The Nottingham prognostic index for invasive carcinoma of the breast. [My Copy] Pathology oncology research : POR, Vol. 14, No. 2. (1 June 2008), pp. 113-115. by Andrew H. Lee, Ian O. Ellis posted to prognosis prediction index breast by misonneh on 2009-11-10 05:55:51 as along with 1 person Zephyrus
	Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 11. (1 June 2008), pp. 3494-3502. by Heidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.Georg Hutarew, Roland Reitsamer, Robin L. Jones, Mitch Dowsett, Elisabeth Mueller-Holzner, Gudrun Windbichler, Günter Daxenbichler, Georg Goebel, Christian Ensinger, Ian Jacobs, Martin Widschwendter posted to response prediction pharmacogenetics neurod1 neoadjuvant methylation gene_specific_methylation epigenetics circ_dna chemotherapy breast by misonneh on 2009-11-04 21:21:37 as
	Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. [My Copy] British journal of cancer, Vol. 101, No. 8. (20 October 2009), pp. 1253-1260. by M. Hauglid Flågeng, Haugan L. Moi, J. M. Dixon, et al.J. Geisler, E. A. Lien, W. R. Miller, P. E. Lønning, G. Mellgren posted to response prediction nuclear_receptor neoadjuvant kim_ her2 expression breast aromatase_inhibitor by misonneh on 2009-11-03 06:03:37 as
	Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. [My Copy] Human genetics (8 October 2009) by Cristina Rodriguez-Antona, Alvin Gomez, Maria Karlgren, Sarah C. Sim, Magnus Ingelman-Sundberg posted to review response prediction methylation kim_ epidgenetics chemotherapy by misonneh on 2009-10-29 07:13:34 as
	MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma [My Copy] N Engl J Med, Vol. 352, No. 10. (10 March 2005), pp. 997-1003. by Monika E. Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M. Kros, Johannes A. Hainfellner, Warren Mason, Luigi Mariani, Jacoline E. C. Bromberg, Peter Hau, Rene O. Mirimanoff, J. Gregory Cairncross, Robert C. Janzer, Roger Stupp posted to temozolomide response prognosis prediction mgmt kim_ glioblastoma gene_specific_methylation epigenetics chemotherapy alkylating_agents by misonneh on 2009-10-29 07:06:02 as along with 2 people srp33 alanvelander
	Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 25. (1 September 2008), pp. 4189-4199. by Monika E. Hegi, Lili Liu, James G. Herman, et al.Roger Stupp, Wolfgang Wick, Michael Weller, Minesh P. Mehta, Mark R. Gilbert posted to response prognosis prediction mgmt methylation kim_ glioblastoma gene_specific_methylation by misonneh on 2009-10-29 06:53:05 as along with 2 people cornellneurology lrust
	Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen [My Copy] JAMA, Vol. 302, No. 13. (7 October 2009), pp. 1429-1436. by Werner Schroth, Matthew P. Goetz, Ute Hamann, et al.Peter A. Fasching, Marcus Schmidt, Stefan Winter, Peter Fritz, Wolfgang Simon, Vera J. Suman, Matthew M. Ames, Stephanie L. Safgren, Mary J. Kuffel, Hans U. Ulmer, Julia Bolander, Reiner Strick, Matthias W. Beckmann, Heinz Koelbl, Richard M. Weinshilboum, James N. Ingle, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch posted to tamoxifen prognosis prediction pharmacogenetics genotype cyp2d6 breast by misonneh on 2009-10-26 06:36:40 as along with 2 people songpku merpublic
	CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. [My Copy] Breast cancer research : BCR, Vol. 9, No. 6. (17 December 2007), R87. by Francisco J. Esteva, Jing Wang, Feng Lin, et al.Jaime A. Mejia, Kai Yan, Kadri Altundag, Vicente Valero, Aman U. Buzdar, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai posted to response prediction neoadjuvant immunity her2 breast biomarker by misonneh on 2009-10-19 08:49:42 as
	Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 3. (6 February 2008), pp. 207-212. by Giuseppe Viale, Meredith M. Regan, Mauro G. Mastropasqua, et al.Fausto Maffini, Eugenio Maiorano, Marco Colleoni, Karen N. Price, Rastko Golouh, Tiziana Perin, R. W. Brown, Anikó Kovács, Komala Pillay, Christian Ohlschlegel, Barry A. Gusterson, Monica Castiglione-Gertsch, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, International Breast Cancer Study Group posted to prognosis prediction ki67 hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:47:32 as
	Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 8. (10 March 2008), pp. 1275-1281. by Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, et al.Fabrice André, Attila Tordai, Jaime A. Mejia, W. Fraser Symmans, Ana M. Gonzalez-Angulo, Bryan Hennessy, Marjorie Green, Massimo Cristofanilli, Gabriel N. Hortobagyi, Lajos Pusztai posted to survival prognosis prediction neoadjuvant chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:43 as
	The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer. [My Copy] Breast cancer research and treatment, Vol. 116, No. 1. (1 July 2009), pp. 53-68. by Robin L. Jones, Janine Salter, Roger A'Hern, et al.Ash Nerurkar, Marina Parton, Jorge S. Reis-Filho, Ian E. Smith, Mitchell Dowsett posted to prediction neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:39:43 as along with 1 person Zephyrus
	Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 5. (10 February 2008), pp. 814-819. by Julie R. Gralow, Harold J. Burstein, William Wood, et al.Gabriel N. Hortobagyi, Luca Gianni, Gunter von Minckwitz, Aman U. Buzdar, Ian E. Smith, William F. Symmans, Baljit Singh, Eric P. Winer posted to review response prognosis prediction neoadjuvant breast by misonneh on 2009-10-19 08:15:04 as
	Supervised risk predictor of breast cancer based on intrinsic subtypes. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 8. (10 March 2009), pp. 1160-1167. by Joel S. Parker, Michael Mullins, Maggie C. Cheang, et al.Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu, John F. Quackenbush, Inge J. Stijleman, Juan Palazzo, J. S. Marron, Andrew B. Nobel, Elaine Mardis, Torsten O. Nielsen, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard posted to time_to_event subtypes risk_assessment response prognosis prediction genetics breast by misonneh on 2009-10-19 08:08:31 as along with 3 people Zephyrus ptrobajo jfr
	Body Mass Index, Height, and Risk of Lymphatic Malignancies: A Prospective Cohort Study [My Copy] Am. J. Epidemiol., Vol. 170, No. 3. (1 August 2009), pp. 297-307. by Romana D. Pylypchuk, Leo J. Schouten, R. Alexandra Goldbohm, Harry C. Schouten, Piet A. van den Brandt posted to cohort leukemia lifestyle prediction risk_factor by misonneh on 2009-07-27 09:40:20 as
	A Holy Grail of Clinical Pharmacology: Prediction of Drug Pharmacokinetics and Pharmacodynamics in the Individual Patient [My Copy] Clin Pharmacol Ther, Vol. 86, No. 2. (21 July 2009), pp. 133-134. by L. Z. Benet posted to comments cyp3a4 pharmacogenetics pk prediction by misonneh on 2009-07-22 03:33:40 as
	MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. [My Copy] Cancer research, Vol. 69, No. 14. (15 July 2009), pp. 5776-5783. by Mitch Raponi, Lesley Dossey, Tim Jatkoe, et al.Xiaoying Wu, Guoan Chen, Hongtao Fan, David G. Beer posted to array cluster epigenetics lung mirna prediction prognosis survival by misonneh on 2009-07-15 09:14:52 as along with 2 people and 1 group frohike giovenko MGEL Reading
	Prediction of Drug Response in Breast Cancer Using Integrative Experimental/Computational Modeling [My Copy] Cancer Res, Vol. 69, No. 10. (15 May 2009), pp. 4484-4492. by Hermann B. Frieboes, Mary E. Edgerton, John P. Fruehauf, et al.Felicity R. Rose, Lisa K. Worrall, Robert A. Gatenby, Mauro Ferrari, Vittorio Cristini posted to breast insilico modeling pharmacogenetics prediction response by misonneh on 2009-05-21 05:34:43 as
	Genetic risk prediction--are we there yet? [My Copy] The New England journal of medicine, Vol. 360, No. 17. (23 April 2009), pp. 1701-1703. by P. Kraft, D. J. Hunter posted to genetics perspective pharmacogenetics prediction public risk_factor by misonneh on 2009-04-16 02:57:02 as along with 5 people guhjy austin_mcdonald srp33 psique jbhiatt
	Beyond the Gail model: lobular involution may help refine breast cancer risk assessment. [My Copy] Journal of the National Cancer Institute, Vol. 101, No. 3. (4 February 2009), pp. 134-135. by K. Rowan posted to modeling breast prediction statistics by misonneh on 2009-03-19 07:53:42 as
	Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics [My Copy] Pharmacogenomics, Vol. 9, No. 12., pp. 1809-1823. by Hamid Mostafavi M. Abdolmaleky, Jin-Rong Zhou, Sam Thiagalingam, Cassandra L. Smith posted to epigenetics pharmacogenetics prediction psychoses review by misonneh on 2009-03-11 05:49:36 as
	Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response [My Copy] Pharmacogenomics, Vol. 9, No. 12., pp. 1903-1916. by Kim M. Smits, Arjen H. G. Cleven, Matty P. Weijenberg, et al.Laura A. E. Hughes, James G. Herman, Adriaan P. de Bruine, Manon van Engeland posted to colon epigenetics pharmacogenetics prediction progression review by misonneh on 2009-03-11 05:47:18 as
	Structural variation in the human genome: the impact of copy number variants on clinical diagnosis. [My Copy] Genetics in Medicine, Vol. 9, No. 9. (September 2007), pp. 600-606. by L. Rodriguez-Revenga, M. Mila, C. Rosenberg, A. Lamb, C. Lee posted to cnv diagnosis genetics prediction review by misonneh on 2008-10-29 10:03:07 as along with 3 people and 1 group brianb frohike Zephyrus Roswell Cancer Crosstalk
	Discriminatory Accuracy From Single-Nucleotide Polymorphisms in Models to Predict Breast Cancer Risk [My Copy] J. Natl. Cancer Inst., Vol. 100, No. 14. (16 July 2008), pp. 1037-1041. by Mitchell H. Gail posted to breast genetics modeling prediction by misonneh on 2008-10-29 09:45:03 as along with 2 people and 1 group Zephyrus srp33 Breast Cancer Reading Club
	Predicting lung cancer by detecting aberrant promoter methylation in sputum. [My Copy] Cancer research, Vol. 60, No. 21. (1 November 2000), pp. 5954-5958. by W. A. Palmisano, K. K. Divine, G. Saccomanno, et al.F. D. Gilliland, S. B. Baylin, J. G. Herman, S. A. Belinsky posted to diagnosis gene_specific_methylation lung prediction target_dna by misonneh on 2008-10-17 15:03:01 as
	Performance of BRCA1/2 Mutation Prediction Models in Asian Americans [My Copy] J Clin Oncol, Vol. 26, No. 29. (10 October 2008), pp. 4752-4758. by Allison W. Kurian, Gail D. Gong, Nicolette M. Chun, et al.Meredith A. Mills, Ashley D. Staton, Kerry E. Kingham, Beth B. Crawford, Robin Lee, Salina Chan, Susan S. Donlon, Yolanda Ridge, Karen Panabaker, Dee W. West, Alice S. Whittemore, James M. Ford posted to brca12 modeling prediction by misonneh on 2008-10-09 08:15:11 as
	Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer [My Copy] N Engl J Med, Vol. 358, No. 26. (26 June 2008), pp. 2796-2803. by Paul D. P. Pharoah, Antonis C. Antoniou, Douglas F. Easton, Bruce A. J. Ponder posted to breast genetics prediction prevention by misonneh on 2008-10-03 21:05:53 as along with 5 people and 2 groups aeisen Zephyrus songpku guhjy balicea Roswell Cancer Crosstalk Breast Cancer Reading Club
	Circulating methylated DNA: a new generation of tumor markers. [My Copy] Clinical Cancer Research, Vol. 12, No. 24. (15 December 2006), pp. 7205-7208. by M. Widschwendter, U. Menon posted to biomarker circ_dna comments diagnosis epigenetics methylation prediction prevention by misonneh on 2008-09-24 15:23:13 as
	Double-Strand Break Damage and Associated DNA Repair Genes Predispose Smokers to Gene Methylation [My Copy] Cancer Res, Vol. 68, No. 8. (15 April 2008), pp. 3049-3056. by Shuguang Leng, Christine A. Stidley, Randy Willink, et al.Amanda Bernauer, Kieu Do, Maria A. Picchi, Xin Sheng, Melissa A. Frasco, David Van Den Berg, Frank D. Gilliland, Christopher Zima, Richard E. Crowell, Steven A. Belinsky posted to biomarker cohort dna_repair gene_specific_methylation lung prediction prevention sputum diagnosis smoking by misonneh on 2008-09-24 15:22:17 as along with 1 person TOchi
	Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum [My Copy] British Journal of Cancer, Vol. aop, No. current. (03 April 2007) by S. A. Belinsky, M. J. Grimes, E. Casas, et al.C. A. Stidley, W. A. Franklin, T. J. Bocklage, D. H. Johnson, J. H. Schiller posted to peripheral biomarker cohort gene_specific_methylation lung prediction target_dna by misonneh on 2008-09-24 15:20:25 as
	Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. [My Copy] Cancer research, Vol. 66, No. 6. (15 March 2006), pp. 3338-3344. by S. A. Belinsky, K. C. Liechty, F. D. Gentry, et al.H. J. Wolf, J. Rogers, K. Vu, J. Haney, T. C. Kennedy, F. R. Hirsch, Y. Miller, W. A. Franklin, J. G. Herman, S. B. Baylin, P. A. Bunn, T. Byers posted to gene_specific_methylation lung prediction prevention target_dna by misonneh on 2008-09-24 15:19:19 as
	Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes. [My Copy] BMC Medical Genetics, Vol. 6 (14 June 2005) by J. J. Latimer, W. S. Rubinstein, J. M. Johnson, A. Kanbour-Shakir, V. G. Vogel, S. G. Grant posted to biomarker breast prediction peripheral by misonneh on 2008-09-23 20:12:33 as
	A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan. [My Copy] Mutagenesis, Vol. 21, No. 1. (January 2006), pp. 41-47. by X. Wang, X. Wu, Z. Liang, Y. Huang, M. Fenech, J. Xue posted to biomarker breast folate instability prediction peripheral by misonneh on 2008-09-23 20:09:41 as
	Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. [My Copy] Oncogene, Vol. 23, No. 54. (18 November 2004), pp. 8841-8846. by K. Chalitchagorn, S. Shuangshoti, N. Hourpai, et al.N. Kongruttanachok, P. Tangkijvanich, D. Thong-ngam, N. Voravud, V. Sriuranpong, A. Mutirangura posted to global line1 methylation prediction by misonneh on 2008-09-23 18:58:39 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/prediction

review	312
breast	263
genetics	168
epigenetics	161
methylation	153
pharmacogenetics	143
statistics	90
gene_specific_methylation	66
biomarker	65
comments	65
gwas	64
prognosis	61
meta_analysis	55
association	54
tamoxifen	53
chemotherapy	50
moa	47
peripheral	47
gxe	46
diet	43
folate	40
modeling	38
response	38
resistance	36
survival	36
guideline	35
global	33
prediction	33
epidemiology	31
adr	30
epistasis	30
dynamic	28
korean	28
prostate	28
time_to_event	28
technology	27
diagnosis	26
haplotype	26
cyp2d6	23
expression	23
race	23
neoadjuvant	22
circ_dna	21
colon	21
instability	21
environment	20
prevention	20
database	19
progression	19
lung	17
perspective	17
pooling	17
risk_factor	17
line1	16
therapy	16
immunity	15
target_dna	14
1-carbon	13
clinic	13
hr	13
invivo	13
kfdap_112909	13
phenotype	13
randomized_controlled_trial	13
tool	13
5mdc	12
age	12
tutorial	12
gxg	11
hematology	11
metastasis	11
mirna	11
pk	11
bladder	10
data_mining	10
estrogen	10
exposure	9
her2	9
hormone	9
mdr1	9
pathway	9
smoking	9
bias	8
cancer	8
design	8
epilepsy	8
esr1	8
fda	8
gst	8
heterogeneity	8
ivive	8
lifestyle	8
reproductive	8
cnv	7
dnmt	7
etiology	7
hla	7
kim_	7
metabolism	7
mthfr	7
power	7
prenatal	7
subtypes	7
trend	7
alcohol	6
carbamazepine	6
cell	6
cohort	6
cyp450	6
ddi	6
dna_repair	6
drug_discovery	6
histone	6
hyper_hypo	6
maternal	6
methodology	6
pcb	6
summary	6
system_biology	6
array	5
benign	5
cervix	5
chemoprevention	5
fundamental_concept_s1	5
inheritance	5
intervention	5
mgmt	5
mhc	5
microarray	5
mortality	5
nos3	5
pet	5
translation	5
asian_populations	4
balanced	4
basal-like	4
bayesian	4
biobank	4
bmd	4
cimp	4
cns	4
detection	4
disparities	4
leukemia	4
linkage	4
ntissue	4
observation	4
pathology	4
refractory	4
transport	4
triple-negative	4
tsnp	4
aml	3
antioxidant	3
cluster	3
cyp1a1	3
cytokine	3
demethylation	3
egfr_pathway	3
fu	3
glioblastoma	3
hitchhiking	3
intrauterine	3
mds	3
metformin	3
molecular	3
ovarian	3
public	3
risk_assessment	3
ros	3
statin	3
sult1a1	3
sult1e1	3
swog	3
toxicity	3
validation	3
allergy	2
anthracycline	2
apoptosis	2
aromatase_inhibitor	2
aspirin	2
atm	2
benzopyrene	2
bisphenol	2
brain	2
brca	2
brca12	2
caret	2
childhood	2
classification	2
comt	2
consorcium	2
cyp2c19	2
cyp2e1	2
decitabine	2
definition	2
diabetes	2
endometrix	2
epigenetic_therapy	2
feature_selection	2
finasteride	2
fprp	2
genotype	2
grail	2
hematopoiety	2
immortalization	2
insilico	2
irinotecan	2
iron	2
isoflavone	2
kawasaki	2
key	2
ki67	2
lymphoma	2
mnsod	2
nqo1	2
nutrition	2
oral	2
ovary	2
parent_study	2
pharmacodynamic	2
phase	2
polycomb	2
protocol	2
quantitative_traits	2
radiotherapy	2
s8897	2
slco1b1	2
specimen	2
testicular	2
toxicology	2
tpmt	2
ugt	2
wnt	2
5-alpha_reductase	1
abacavir	1
acs	1
aldh1	1
aldh2	1
alkylating_agents	1
alternative	1
antidepressant	1
assay	1
azacitidine	1
benzene	1
bmp	1
casp8	1
cat	1
catechol	1
cbr3	1
cdk	1
cell_cycle_control	1
cisplatin	1
cml	1
compliance	1
confounder	1
consortium	1
cyclophosphamide	1
cyp19	1
cyp1a2	1
cyp1b1	1
cyp2c9	1
cyp3a4	1
dag	1
dcic	1
decision	1
diganosis	1
digoxin	1
ecadherin	1
endpoint	1
epidgenetics	1
example	1
family_hx	1
fastsnp	1
fmr1	1
fun	1
glioma	1
gpx1	1
gstp1	1
heritability	1
hif1a	1
histology	1
history	1
hnscc	1
ho1	1
hogg1	1
hpv	1
illumina	1
immunoprecipitation	1
index	1
infection	1
inflammtion	1
integration	1
interleukin	1
invitro	1
journal_club	1
lactation	1
lipidadjust	1
liver	1
mapping	1
maspin	1
mbd2	1
meta_anlaysis	1
metabolomics	1
meternal	1
methotrexate	1
mining	1
mpo	1
mrp3	1
multiple_myeloma	1
multitest	1
myc	1
networking	1
neurod1	1
nhs	1
no	1
nrf2	1
nsaid	1
nuclear_receptor	1
obesity	1
oncotypedx	1
opg	1
oralscc	1
osteoporosis	1
outcome	1
p53	1
parity	1
paternal	1
pax2	1
peakbmd	1
peripheral_blood	1
pharmacogenomics	1
pharmacokinetic_variability	1
phytoestrogen	1
plink	1
polymapr	1
polyphenol	1
population	1
practice	1
prevalence	1
proression	1
psychoses	1
qsar	1
rank	1
rcc	1
read_	1
resonse	1
rfc	1
s100p	1
sat2	1
scn	1
series	1
sfrp5	1
silencing_rna	1
splicing	1
sputum	1
src	1
steroid	1
stromal_component	1
tea	1
temozolomide	1
tgf	1
tgm2	1
tp53	1
twin_study	1
ugt1a1	1
warfarin	1
xpd	1
xrcc1	1
xrcc3	1

misonneh's prediction [33 articles] Export

misonneh's tags